Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia Feyler

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Blood Reviews|April 30, 2013
Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)Sylvia Feyler, Peter J Selby, Gordon Cook
Leukemia Research Reports|December 28, 2013
Durable second complete remissions with oral melphalan in hypocellular Acute Myeloid Leukemia and Refractory Anemia with Excess Blast with normal karyotype relapsing after intensive chemotherapyAnnika M Whittle, Sylvia Feyler, David T Bowen
British Journal of Haematology|February 1, 2011
Feasibility and efficacy of administration of bortezomib-containing regimens to patients over the age of 70 yearsChristopher Parrish, Julian Cromack, Sylvia Feyler, et al.
British Journal of Haematology|October 4, 2007
Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 studySylvia Feyler, Andy Rawstron, Graham Jackson, et al.
American Journal of Hematology|July 16, 2011
Defining IgM multiple myelomaRoger G Owen, Sylvia Feyler, Sheila J M O'Connor, et al.
Plos One|June 6, 2012
Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independentSylvia Feyler, Gina B Scott, Christopher Parrish, et al.
Blood|December 14, 2011
Effect of combined dexamethasone/lenalidomide therapy on NK cell-receptor levels in myeloma patientsClive R Carter, Sylvia Feyler, Natuley Smalle, et al.
British Journal of Haematology|January 13, 2009
CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burdenSylvia Feyler, Marie von Lilienfeld-Toal, Sarah Jarmin, et al.
British Journal of Haematology|April 27, 2011
Guidelines for supportive care in multiple myeloma 2011John A Snowden, Sam H Ahmedzai, John Ashcroft, et al.
British Journal of Haematology|February 16, 2008
IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14)Sylvia Feyler, Sheila J M O'Connor, Andy C Rawstron, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Blood Reviews|April 30, 2013
Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)Sylvia Feyler, Peter J Selby, Gordon Cook
Leukemia Research Reports|December 28, 2013
Durable second complete remissions with oral melphalan in hypocellular Acute Myeloid Leukemia and Refractory Anemia with Excess Blast with normal karyotype relapsing after intensive chemotherapyAnnika M Whittle, Sylvia Feyler, David T Bowen
British Journal of Haematology|February 1, 2011
Feasibility and efficacy of administration of bortezomib-containing regimens to patients over the age of 70 yearsChristopher Parrish, Julian Cromack, Sylvia Feyler, et al.
British Journal of Haematology|October 4, 2007
Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 studySylvia Feyler, Andy Rawstron, Graham Jackson, et al.
American Journal of Hematology|July 16, 2011
Defining IgM multiple myelomaRoger G Owen, Sylvia Feyler, Sheila J M O'Connor, et al.
Plos One|June 6, 2012
Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independentSylvia Feyler, Gina B Scott, Christopher Parrish, et al.
Blood|December 14, 2011
Effect of combined dexamethasone/lenalidomide therapy on NK cell-receptor levels in myeloma patientsClive R Carter, Sylvia Feyler, Natuley Smalle, et al.
British Journal of Haematology|January 13, 2009
CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burdenSylvia Feyler, Marie von Lilienfeld-Toal, Sarah Jarmin, et al.
British Journal of Haematology|April 27, 2011
Guidelines for supportive care in multiple myeloma 2011John A Snowden, Sam H Ahmedzai, John Ashcroft, et al.
British Journal of Haematology|February 16, 2008
IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14)Sylvia Feyler, Sheila J M O'Connor, Andy C Rawstron, et al.
Pageof 3